Dataset from A Phase 3, Prospective, Multicenter Study to Evaluate Efficacy and Safety of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Elective Surgical Procedures in Subjects With Severe Von Willebrand Disease
收藏NIAID Data Ecosystem2026-05-10 收录
下载链接：
https://doi.org/10.25934/00006625
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of the study is to assess the efficacy and safety of recombinant von Willebrand
factor (rVWF) with or without ADVATE in major and minor elective surgical procedures in adult
patients with hereditary severe von Willebrand disease (VWD).
创建时间：
2025-10-29
